ArticleInternational journal of molecular sciences2025
Animal Model Screening for Hyperlipidemic ICR Mice.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lipophagy Dynamics in Hyperlipidemia Model ICR Mice Across Different High-Fat-Diet Feeding Durations.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study aimed to establish a hyperlipidemia model in ICR mice using a homemade high-fat diet. It further investigated hyperlipidemia-related indicators in control and model mice at various feeding durations to determine the optimal time frame for successful model establishment. Sixteen male ICR mice were introduced at intervals of 3 weeks, starting from weeks 0, 3, 6, 9, and 12. The control group was fed a standard diet, while the model group received a homemade high-fat diet to induce hyperlipidemia. Blood lipid related indices were detected at 15 weeks. The liver, scapular fat, abdominal fat, and epididymal fat were harvested to calculate the organ index. The contents of T-CHO, TG, and TBA in the liver were measured. HE staining was used to observe pathological changes in liver tissue and white adipose tissue, while Oil Red O staining was used to observe lipid droplets in liver tissue. The mRNA and protein expression of SREBP-2, insig1, HMGCR, LXRα, ABCA1, and CYP7A1 in the liver were detected by RT-qPCR and Western Blot. In the model group, blood lipid levels significantly increased by the 9th week, aligning with pathological changes indicative of hyperlipidemia. The mRNA and protein expression levels of SREBP-2, Insig-1, HMGCR, LXRα, ABCA1, and CYP7A1 were markedly elevated at 9 weeks and remained relatively stable thereafter. This study provides a reliable reference for determining the optimal establishment time of hyperlipidemia models and for in vivo hyperlipidemia animal experiments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.